Strategic Program Cancer nieuws
Strategic Program Cancer nieuws
Cancer patients want their GP's involvement
Cancer patients need more involvement from their GP after being diagnosed in hospital, including joint decision-making about treatment. However, planning such a joint process is a major challenge. These are the results of 2 UMC Utrecht studies, one by Ietje Perfors and one by Eveline Nooteboom. Continued development of interventions to support primary care involvement in cancer care remains necessary. The need for primary care is obvious, but the design, evaluation and implementation of new interventions remains challenging. Together with other primary and secondary care providers in the region, UMC Utrecht has made collaboration arrangements to provide structured oncological care to improve the counseling of patients with cancer.
Read moreNew research reveals effects of COVID-19 on breast cancer screening, treatment and care
New research reveals effects of COVID-19 on breast cancer screening, treatment and care An increase in deaths could be prevented by ensuring older women do not miss final screening How does the COVID-19 pandemic affect the daily lives of women diagnosed with breast cancer? Dr Claudia Bargon, clinician and PhD student at University Medical Center Utrecht (UMC Utrecht), presents this study at the (online) European Breast Cancer Conference (EBCC) that takes place October 2 & 3.
Read moreIncreased risk of cardiovascular disease in women treated for breast cancer can be predicted
Automated analysis of breast cancer patients’ routine scans can predict which women have a greater than one in four risk of going on to develop cardiovascular disease, according to research presented at the 12th European Breast Cancer Conference.
Read moreLarge variation in histologic grading of breast cancer between pathology laboratories
Quality improvement of biomarker assessment in breast cancer
Read moreOver € 4 million for cancer research in Utrecht
The Dutch Cancer Society (DCS) is investing 4.4 million in 8 studies at Utrecht Science Park. It concerns 5 studies at UMC Utrecht, 2 at the Hubrecht Institute and 1 at the Helen Dowling Institute.
Read moreWarm plea for the Innovation Clinic
“We have to organize our care in such a way that we can actually learn from each patient without losing valuable information. A so-called innovation clinic makes that possible.” Prof. Lenny Verkooijen makes a warm plea for this in a short webinar about ‘learning from implementation’, organized by the Information Council of the Dutch Health Department.
Read moreMedicatietest op gekweekte eierstoktumor is mogelijk
Sinds kort is het mogelijk om bij eierstokkanker uit tumorcellen van een patiënt in het lab mini-eierstoktumoren te kweken om daar medicijnen op te testen. Arts-onderzoeker Chris de Witte laat zien dat de reactie van deze mini-tumoren op geneesmiddelen vrij nauwkeurig de reactie bij deze patiënt voorspelt. Ook DNA-kenmerken van de tumor lijken medebepalend voor het behandelsucces. In de toekomst kunnen deze bevindingen mogelijk helpen om patiënten een behandeling op maat te bieden en zo de overlevingskans te vergroten.
Read moreImproving primary care involvement in cancer care
Thesis dr. Ietje Perfors, Improving primary care involvement in cancer care
Read moreLive from University Hall Lecture Dennis Klomp
For the first time in 384 years, an inaugural lecture will be broadcast live from the University Hall. The scoop is for Professor Dennis Klomp with his lecture, entitled "Powerful Exchange in Images".
Read moreThe RASTRIC trial: new investigator driven clinical trial started
Recently, Hugo Snippert and Hans Bos (both CMM in the UMCU) found a combination of three readily available drugs, that was effective in the lab on models of this disease. Excitingly, this month a phase I/II clinical trial based on their work has officially started. The RASTRIC trial is a first-in-human clinical trial to test this new combination. The trial is led by medical oncologist Jeanine Roodhart and is open for registration.
Read more